Legal Representation
Attorney
Timothy J. Gaul
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 12, 2022 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Oct 12, 2022 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Mar 18, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 18, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 18, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 16, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 28, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicaments, namely, polypeptides, for use in the treatment of tumorous diseases, cancer, allergies, autoimmunity, inflammation, osteoporosis, graft versus host diseases, transplant rejection, cardiovascular diseases, metabolic diseases, neurological diseases, and minimal residual diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 009
Downloadable educational materials on therapeutic polypeptides and use thereof
First Use Anywhere:
0
First Use in Commerce:
0
Class 016
Printed educational materials on therapeutic polypeptides and use thereof; printed educational materials in the field of therapeutic polypeptides and use thereof
First Use Anywhere:
0
First Use in Commerce:
0
Class 035
Promoting interest and awareness among healthcare practitioners and the public regarding therapeutic polypeptides and use thereof; promoting education for healthcare professionals on health and medical issues, namely, therapeutic polypeptides and use thereof
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Providing medical and scientific research information regarding therapeutic polypeptides and use thereof; providing a website featuring medical and scientific research information regarding antibody derivatives and use thereof; providing scientific information regarding antibody derivatives and use thereof; providing a website featuring scientific information regarding antibody derivatives and use thereof
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
D BITE
Classification
International Classes
005
009
016
035
042